4885
MUROMACHI CHEMICALS INC.
室町ケミカル
- Industry
- Pharmaceutical
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Non-consolidated
Key metrics
Revenue(thousand JPY)
May 2022
5,681,099
May 2023
6,291,379
May 2024
6,369,097
May 2025
6,653,028
May 2026
7,840,931
Operating profit(thousand JPY)
May 2022
437,341
May 2023
369,413
May 2024
421,837
May 2025
432,188
May 2026
742,930
Operating profit margin(%)
May 2022
7.7
May 2023
5.87
May 2024
6.62
May 2025
6.5
May 2026
9.48
Profit before tax(thousand JPY)
May 2022
425,603
May 2023
350,900
May 2024
468,586
May 2025
350,048
May 2026
328,076
Profit(thousand JPY)
May 2022
456,272
May 2023
256,302
May 2024
330,197
May 2025
241,277
May 2026
163,027
Total assets(thousand JPY)
May 2022
4,798,071
May 2023
4,948,311
May 2024
5,059,267
May 2025
5,264,574
May 2026
6,352,689
Cash and cash equivalents(thousand JPY)
May 2022
865,361
May 2023
852,606
May 2024
1,050,427
May 2025
1,028,068
May 2026
1,917,059
Cash flows from operating activities(thousand JPY)
May 2022
524,905
May 2023
317,189
May 2024
637,701
May 2025
215,961
May 2026
808,089
Cash flows from investing activities(thousand JPY)
May 2022
-176,280
May 2023
-162,408
May 2024
-232,230
May 2025
-370,504
May 2026
-237,791
Cash flows from financing activities(thousand JPY)
May 2022
-483,635
May 2023
-172,390
May 2024
-209,954
May 2025
123,200
May 2026
317,776
Return on equity(%)
May 2022
30.3
May 2023
14.3
May 2024
15.8
May 2025
10.2
May 2026
6.5
Equity ratio(%)
May 2022
35
May 2023
38.7
May 2024
44.9
May 2025
46.6
May 2026
40.6
Earnings per share(JPY per share)
May 2022
123.79
May 2023
67.94
May 2024
83.42
May 2025
60.42
May 2026
40.58
Net assets per share(JPY per share)
May 2022
450.37
May 2023
487.25
May 2024
571.26
May 2025
612.4
May 2026
640.13
Dividend per share(JPY per share)
May 2022
19
May 2023
19
May 2024
22
May 2025
25
May 2026
26
Payout ratio(%)
May 2022
15.35
May 2023
27.97
May 2024
26.37
May 2025
41.38
May 2026
64.07
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.